对帕金森病诊断文献的综合审查
1VIT University, Vellore, Tamil Nadu 632002, India.
Computational biology and chemistry
|October 16, 2024
概括
本综述分析了50篇关于使用机器学习和各种数据模式诊断帕金森病的文章. 它确定了研究缺陷和障碍,以开发有效的帕金森病诊断工具.
科学领域:
- 神经科学是一个神经科学.
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,影响运动和非运动功能,显著影响生活质量,并产生大量的社会成本.
- 早期诊断PD对于及时干预和管理至关重要,但由于复杂的症状表现,仍然具有挑战性.
研究的目的:
- 系统地审查和分类50篇关于帕金森病诊断的文章.
- 分析PD诊断中各种数据模式 (图像,信号,数据) 和机器学习方法的利用情况.
- 识别人工智能驱动的帕金森病诊断领域的研究缺口和障碍.
主要方法:
- 进行了全面的文献搜索,重点是关于帕金森病诊断发表的研究.
- 文章根据数据模式 (图像,信号,数据) 和所使用的机器学习技术进行分类.
- 分析包括数据集,模拟工具,绩效指标,以及对所选论文的时间顺序审查.
主要成果:
- 该审查对基于多式联网数据和机器学习/深度学习方法的现有研究进行了分类,以诊断帕金森病.
- 分析了PD诊断研究中使用的关键数据集,模拟工具和绩效评估指标.
- 一个按时间顺序的评估突出了基于AI的帕金森病诊断研究的演变和趋势.
结论:
- 机器学习方法在各种数据模式中显示出对帕金森病诊断的重大前景.
- 需要进一步的研究来解决发现的差距,特别是在数据集的标准化和模型的验证现实世界的临床应用.
- 通过先进的人工智能技术优化诊断准确性和效率仍然是改善帕金森病患者治疗结果的关键目标.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.6K
相关概念视频
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Parkinson's Disease: Treatment
231
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
231
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Diagnostic and Statistical Manual of Mental Disorders (DSM)
45
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
45
